Aladdin Healthcare Technologies SE Logo

Aladdin Healthcare Technologies SE

Develops AI-powered tools for drug discovery and diagnostics for age-related conditions.

NMI | BE

Overview

Corporate Details

ISIN(s):
DE000A12ULL2
LEI:
391200M0N1PWTP19RE15
Country:
Germany
Address:
Unter den Linden 10, 10117 Berlin

Description

Aladdin Healthcare Technologies SE is a healthcare technology company that leverages artificial intelligence for drug discovery and diagnostics. The company's primary focus is on developing solutions for age-related conditions, with a significant emphasis on Alzheimer's disease. It utilizes a proprietary AI platform for virtual screening to identify novel small molecule drug compounds. In addition to drug development, the company develops AI-powered diagnostic tools and health screening services, which include applications for advanced image processing and analysis.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2022-09-02 16:41
Aladdin Healthcare Technologies SE: Antrag auf Eroffnung eines Insolvenzverfahr…
German 4.8 KB
2022-08-15 13:30
Aladdin Healthcare Technologies SE: Notice of fine by BaFin in the total amoun…
English 5.1 KB
2022-02-02 16:46 English 15.1 KB
2022-02-02 15:25
DGAP-DD: Aladdin Healthcare Technologies SE english
English 7.7 KB
2022-02-01 17:01 English 14.2 KB
2022-02-01 15:54 English 14.1 KB
2021-12-03 10:51 English 14.2 KB
2021-11-24 09:00
Aladdin Healthcare Technologies SE approved for Listing on OTCQB in the USA
English 8.7 KB
2021-11-03 09:00 English 3.5 KB
2021-11-02 16:51 English 15.2 KB
2021-11-02 16:47 English 13.9 KB
2021-09-28 11:35 English 3.9 KB
2021-09-23 18:41 English 15.1 KB
2021-09-20 19:34
DGAP-DD: Aladdin Healthcare Technologies SE english
English 7.6 KB
2021-07-14 08:36
Aladdin Healthcare Technologies with new research findings on COVID-19 diagnosis
English 10.2 KB

Automate Your Workflow. Get a real-time feed of all Aladdin Healthcare Technologies SE filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Aladdin Healthcare Technologies SE

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Aladdin Healthcare Technologies SE via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2022-02-02 Menpes-Smith, Mr Wade Board Other None 211,425.00 EUR
2021-09-21 Continental Aktiengesellschaft Close relation Sell None 243,288.00 EUR
2021-09-20 Smith, Wade Board Other None 211,425.00 EUR

Peer Companies

Alteogen Inc. Logo
Biopharmaceutical firm developing biologics with proprietary drug delivery technologies.
South Korea
196170
AlzeCure Pharma Logo
Develops therapies for severe diseases, focusing on Alzheimer's and pain.
Sweden
ALZCUR
ANAPTYSBIO, INC Logo
Clinical-stage biotech developing immunology therapeutics for inflammatory diseases.
United States of America
ANAB
AngioLab, Inc. Logo
Develops angiogenesis inhibitors for pharmaceuticals and health functional foods.
South Korea
251280
Anixa Biosciences Inc Logo
A clinical-stage biotech developing therapies and vaccines to treat and prevent cancer.
United States of America
ANIX
Annovis Bio, Inc. Logo
A clinical-stage drug platform company developing therapies for neurodegenerative diseases.
United States of America
ANVS
Develops and manufactures DNA-based technologies for genetic medicine and diagnostics.
United States of America
APDN
Aprea Therapeutics, Inc. Logo
Clinical-stage biopharma developing cancer therapeutics via synthetic lethality.
United States of America
APRE
AprilBio Co.,Ltd. Logo
Develops long-acting biologic drugs for autoimmune diseases, oncology, and rare diseases.
South Korea
397030
Aptahem AB Logo
A clinical-stage biotech developing aptamer-based drugs for life-threatening conditions.
Sweden
APTA

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.